Cargando…
Effective treatment of advanced alveolar soft part sarcoma with sunitinib: A case report
RATIONALE: Alveolar soft part sarcoma (ASPS) is a very rare soft tissue sarcoma. ASPS often occurs in deep soft tissues of the lower extremities, and develops into metastatic diseases. Chemotherapy is considered to be ineffective in patients with ASPS, which constitutes a very important clinical cha...
Autores principales: | Ye, Chenyang, Wang, Ji, Li, Wenshan, Yuan, Mingjing, Chai, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320175/ https://www.ncbi.nlm.nih.gov/pubmed/30572461 http://dx.doi.org/10.1097/MD.0000000000013584 |
Ejemplares similares
-
Randomized Phase II Trial of Sunitinib or Cediranib in Alveolar Soft Part Sarcoma
por: Nguyen, James, et al.
Publicado: (2023) -
Advances in treatment of alveolar soft part sarcoma: an updated review
por: Fujiwara, Tomohiro, et al.
Publicado: (2023) -
Metastatic Alveolar Soft Part Sarcoma Responsive to Pazopanib after Progression through Sunitinib and Bevacizumab: Two Cases
por: Read, William L., et al.
Publicado: (2016) -
Advanced alveolar soft part sarcoma responds to apatinib
por: Zhou, Yong, et al.
Publicado: (2017) -
Alveolar soft part sarcoma of the forearm
por: Asokan, B., et al.
Publicado: (2017)